INS and type 2 diabetes mellitus: Although initially identified as a potent stimulator of glucose-dependent insulin secretion, its action was found to be markedly diminished in patients with T2DM, leading to the assumption that GIP was rendered functionally irrelevant in the diabetic state [3].